SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 98 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $1,450,000 | +9.1% | 203,128 | -0.3% | 0.05% | +10.2% |
Q2 2014 | $1,329,000 | -5.8% | 203,838 | -4.5% | 0.05% | -9.3% |
Q1 2014 | $1,411,000 | +38.7% | 213,433 | -0.5% | 0.05% | +38.5% |
Q4 2013 | $1,017,000 | -5.0% | 214,597 | -0.5% | 0.04% | -11.4% |
Q3 2013 | $1,070,000 | -13.3% | 215,759 | -9.4% | 0.04% | -17.0% |
Q2 2013 | $1,234,000 | – | 238,038 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |